Chitinase 3-like 1 gene (T/C) polymorphism and serum YKL-40 levels in patients with hepatocellular carcinoma
The chitinase 3-like 1 (CHI3L1) gene encodes the YKL-40 protein. Serum YKL-40 levels are controlled by polymorphisms in the CHI3L1 gene. We aimed to examine the association of the rs880633 (T/C) polymorphism in the CHI3L1 gene with serum YKL-40 levels and to evaluate the role of this polymorphism as...
Saved in:
Published in | Meta Gene Vol. 24; p. 100686 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier B.V
01.06.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The chitinase 3-like 1 (CHI3L1) gene encodes the YKL-40 protein. Serum YKL-40 levels are controlled by polymorphisms in the CHI3L1 gene. We aimed to examine the association of the rs880633 (T/C) polymorphism in the CHI3L1 gene with serum YKL-40 levels and to evaluate the role of this polymorphism as a risk factor for HCC and its effect on patient survival. A total of 225 subjects were categorized into two groups: group I included 120 patients with HCC, and group II involved 105 age and gender-matched healthy volunteers. Genotypes of the rs880633 (T/C) polymorphism in the CHI3L1 gene were analyzed using an allele discrimination assay with real-time PCR, and serum YKL-40 levels were determined using an ELISA technique. A significant difference in the genotype frequency of the T/C polymorphism in the CHI3L1 gene was observed between the two groups, with an increase in the frequency of the CC genotype observed among patients with HCC. Regarding the allelic distribution, the C allele was significantly predominant in patients, with HCC presenting with an increased HCC risk compared to the T allele. Subjects with the CC genotype had the highest serum YKL-40 levels, followed by those with the TC genotype, while subjects with the TT genotype had the lowest serum YKL-40 levels. An analysis of the overall survival of HCC patients revealed that patients with both the CC and CT genotypes displayed a significantly shorter survival rate than patients carrying the TT genotype.
The rs880633 polymorphism in the CHI3L1 gene may be a risk element for HCC. Patients with the CC genotype displayed the highest serum YKL-40 levels, which were linked to poor prognosis.
•SNP rs880633 at CHI3L1 gene may be a potential risk factor for HCC progression.•HCC patients carrying CC and TC genotypes have the highest serum CHI3L1 or YKL40 levels•HCC patients carrying CC genotype have bad prognosis and short survival•SNP rs880633 at CHI3L1 gene could predict the overall survival and disease outcome. |
---|---|
AbstractList | The chitinase 3-like 1 (CHI3L1) gene encodes the YKL-40 protein. Serum YKL-40 levels are controlled by polymorphisms in the CHI3L1 gene. We aimed to examine the association of the rs880633 (T/C) polymorphism in the CHI3L1 gene with serum YKL-40 levels and to evaluate the role of this polymorphism as a risk factor for HCC and its effect on patient survival. A total of 225 subjects were categorized into two groups: group I included 120 patients with HCC, and group II involved 105 age and gender-matched healthy volunteers. Genotypes of the rs880633 (T/C) polymorphism in the CHI3L1 gene were analyzed using an allele discrimination assay with real-time PCR, and serum YKL-40 levels were determined using an ELISA technique. A significant difference in the genotype frequency of the T/C polymorphism in the CHI3L1 gene was observed between the two groups, with an increase in the frequency of the CC genotype observed among patients with HCC. Regarding the allelic distribution, the C allele was significantly predominant in patients, with HCC presenting with an increased HCC risk compared to the T allele. Subjects with the CC genotype had the highest serum YKL-40 levels, followed by those with the TC genotype, while subjects with the TT genotype had the lowest serum YKL-40 levels. An analysis of the overall survival of HCC patients revealed that patients with both the CC and CT genotypes displayed a significantly shorter survival rate than patients carrying the TT genotype.
The rs880633 polymorphism in the CHI3L1 gene may be a risk element for HCC. Patients with the CC genotype displayed the highest serum YKL-40 levels, which were linked to poor prognosis.
•SNP rs880633 at CHI3L1 gene may be a potential risk factor for HCC progression.•HCC patients carrying CC and TC genotypes have the highest serum CHI3L1 or YKL40 levels•HCC patients carrying CC genotype have bad prognosis and short survival•SNP rs880633 at CHI3L1 gene could predict the overall survival and disease outcome. |
ArticleNumber | 100686 |
Author | Alhanafy, Alshimaa M. El-Hefnawy, Sally M. Saleh, Amany A. Elbahr, Osama |
Author_xml | – sequence: 1 givenname: Amany A. surname: Saleh fullname: Saleh, Amany A. email: amanybio@yahoo.com, amany.saleh@med.menofia.edu.eg organization: Medical Biochemistry & Molecular Biology, Egypt – sequence: 2 givenname: Alshimaa M. surname: Alhanafy fullname: Alhanafy, Alshimaa M. organization: Clinical Oncology & Nuclear Medicine Departments, Faculty of Medicine, Menoufia University, Egypt – sequence: 3 givenname: Osama surname: Elbahr fullname: Elbahr, Osama email: osama.elbahr@liver.menofia.edu.eg organization: Hepatology and Gastroenterology Department, National Liver Institute, Menoufia University, Egypt – sequence: 4 givenname: Sally M. orcidid: 0000-0003-3090-0141 surname: El-Hefnawy fullname: El-Hefnawy, Sally M. email: doctor_sally@rocketmail.com organization: Medical Biochemistry & Molecular Biology, Egypt |
BookMark | eNp9kD9PwzAQxS1UJErpJ2DxCEPac5yYZmBAFf9EJZYyMFmucyYujhPZaVG_PQllYGK6u3d6T3q_czLyjUdCLhnMGDAx387qD_Q4SyEdFBALcULGacqyJM8ARn_2MzKNcQsALGVFzsSYuGVlO-tVRMoTZz-RMjqk0av1fHlN28Yd6ia0lY01Vb6kEcOupu8vqyQD6nCPLlLraas6i76L9Mt2Fa2wvxuNzu2cClSroK1vanVBTo1yEae_c0LeHu7Xy6dk9fr4vLxbJZoD75JNBgJMpstUQJ6XYpEVpSqM4jdojNiY_mm4MoUxUCqRqiznDAvOc5UahE3OJ4Qfc3VoYgxoZBtsrcJBMpADM7mVP8zkwEwemfWu26Or74R7i0FG3ZfSWNqAupNlY__1fwN-PnfC |
CitedBy_id | crossref_primary_10_1002_iub_2444 crossref_primary_10_3390_ijms25126768 crossref_primary_10_3390_ijms23042361 crossref_primary_10_1111_jcmm_18012 |
Cites_doi | 10.1016/S0014-4827(03)00069-7 10.1158/1535-7163.MCT-10-0868 10.1007/s11010-014-2277-y 10.1189/jlb.3VMR0415-142R 10.1371/journal.pone.0005469 10.1084/jem.20081271 10.1086/510438 10.1111/j.1440-1789.2011.01252.x 10.1016/j.rmed.2006.12.006 10.1074/jbc.M306792200 10.1159/000444855 10.1016/j.cyto.2010.12.018 10.1038/s41598-018-33239-8 10.3748/wjg.15.5249 10.1371/journal.pone.0024399 10.1245/s10434-010-0985-4 10.1016/j.clinbiochem.2010.07.017 10.1042/bj20020075 10.1007/s12026-013-8459-y 10.1038/srep35282 10.1200/JCO.2008.18.8367 10.1056/NEJMoa060570 10.1245/s10434-011-2026-3 10.7150/ijms.17754 10.1111/j.1478-3231.2011.02686.x 10.1038/onc.2009.292 10.1002/pros.20311 10.1097/00000421-198212000-00014 10.3889/oamjms.2015.111 10.3322/caac.21208 10.1158/1078-0432.CCR-04-1765 |
ContentType | Journal Article |
Copyright | 2020 Elsevier B.V. |
Copyright_xml | – notice: 2020 Elsevier B.V. |
DBID | AAYXX CITATION |
DOI | 10.1016/j.mgene.2020.100686 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2214-5400 |
ExternalDocumentID | 10_1016_j_mgene_2020_100686 S2214540020300414 |
GroupedDBID | --M 0SF 4.4 457 5VS 6I. AACTN AAEDT AAEDW AAFTH AAIAV AAIKJ AAKOC AALRI AAOAW AAXUO ABMAC ABUDA ABYKQ ACDAQ ACGFS ACRLP ADBBV ADEZE AEBSH AEHWI AEXQZ AFKWA AFTJW AFXIZ AGHFR AGUBO AIEXJ AIKHN AITUG AJBFU ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AOIJS AXJTR BAWUL BKOJK DIK EBS EFJIC EFLBG EJD FDB FIRID FYGXN GX1 HYE IXB KOM KQ8 M41 NCXOZ OK1 ROL RPM SPCBC SSU SSZ T5K 0R~ AAQFI AAXKI AAYXX ADVLN AKRWK CITATION |
ID | FETCH-LOGICAL-c303t-b4060f4cd26055d6849da9fa37eff6bf60ff3af9ff0da62a4531e9335a2fe0b53 |
IEDL.DBID | IXB |
ISSN | 2214-5400 |
IngestDate | Thu Sep 12 17:02:07 EDT 2024 Fri Feb 23 02:49:23 EST 2024 |
IsPeerReviewed | false |
IsScholarly | false |
Keywords | HCC YKL-40 Chitinase 3-like 1 Polymorphism |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c303t-b4060f4cd26055d6849da9fa37eff6bf60ff3af9ff0da62a4531e9335a2fe0b53 |
ORCID | 0000-0003-3090-0141 |
ParticipantIDs | crossref_primary_10_1016_j_mgene_2020_100686 elsevier_sciencedirect_doi_10_1016_j_mgene_2020_100686 |
PublicationCentury | 2000 |
PublicationDate | June 2020 2020-06-00 |
PublicationDateYYYYMMDD | 2020-06-01 |
PublicationDate_xml | – month: 06 year: 2020 text: June 2020 |
PublicationDecade | 2020 |
PublicationTitle | Meta Gene |
PublicationYear | 2020 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Shao, Hamel, Petersen, Cao, Arenas, Bigelow, Bentley, Yan (bb0155) 2009; 28 Lee, Hartl, Lee, Koller, Matsuura, Da Silva, Sohn, Cohn, Homer, Kozhich, Humbles, Kearley, Coyle, Chupp, Reed, Flavell, Elias (bb0085) 2009; 206 Faibish, Francescone, Bentley, Yan, Shao (bb0040) 2011; 10 Di Rosa, Malaguarnera (bb0015) 2016; 83 Lee, Kang, Jee, Yoon (bb0090) 2010; 43 Zhao, Tang, Gao, Shi, Zhou, Guo, Zhang, Wang, Tang, Meng, Li, Wang, Ma, Lin, Xiao, Feng, Lin, Zhu, Xing, Sang, St. Clair, He (bb0165) 2007; 80 Kumagai, Mano, Yoshio, Shoji, Sugiyama, Korenaga, Ishida, Arai, Itokawa, Atsukawa, Hyogo, Chayama, Ohashi, Ito, Yoneda, Kawaguchi, Torimura, Nozaki, Watanabe, Mizokami, Kanto (bb0080) 2016; 6 Huang, Lin, Yeh, Chen, Chou, Yang, Liu (bb0055) 2017; 14 Pelloski, Mahajan, Maor, Chang, Woo, Gilbert, Colman, Yang, Ledoux, Blair, Passe, Jenkins, Aldape (bb0125) 2005; 11 Antonelli, Massimino, Morra, Garrè, Gardiman, Buttarelli, Arcella, Giangaspero (bb0005) 2012; 32 Johansen, Bojesen, Mylin, Frikke-Schmidt, Price, Nordestgaard (bb0070) 2009; 27 Erfan, Guzel, Alpsoy, Rifaioglu, Kaya, Kucukyalcın, Topcu, Kulac (bb0030) 2015; 400 Shaker (bb0150) 2016 Zhu, Chen, Tian, Su, Wang, Gai, Du, Ma (bb0175) 2012; 19 El-Zayadi, Badran, Barakat, Attia, Shawky, Mohamed, Selim, Saeid (bb0025) 2005; 11 Mohammadian, Mahdavifar, Mohammadian-Hafshejan, Salehiniya (bb0105) 2018; 5 Oken, Creech, Tormey, Horton, Davis, McFadden, Carbone (bb0115) 1982; 5 Brasso, Christensen, Johansen, Teisner, Garnero, Price, Iversen (bb0010) 2006; 66 Libreros, Garcia-Areas, Iragavarapu-Charyulu (bb0100) 2013; 57 Johansen (bb0065) 2006; 53 Edge, Compton (bb0020) 2010 Kruit, Grutters, Ruven, van Moorsel, van den Bosch (bb0075) 2007; 101 Zheng, Lu, Hu, Zhang, Zhang, Chen, Shen (bb0170) 2011; 54 Janevska, Chaloska-Ivanova, Janevski (bb0060) 2015; 3 Qiu, Wang, Jin, Liu, Liu, Ma, Mao, Ma, Zhao, Chen, Lin (bb0130) 2018; 8 Olaussen, Dunant, Fouret, Brambilla, André, Haddad, Taranchon, Filipits, Pirker, Popper, Stahel, Sabatier, Pignon, Tursz, Le Chevalier, Soria (bb0120) 2006; 355 Hector, Kormann, Mack, Latzin, Casaulta, Kieninger, Zhou, Yildirim, Bohla, Rieber, Kappler, Koller, Eber, Eickmeier, Zielen, Eickelberg, Griese, Mall, Hartl (bb0050) 2011; 6 Rehli, Niller, Ammon, Langmann, Schwarzfischer, Andreesen, Krause (bb0145) 2003; 278 Fontana, Litman, Dienstag, Bonkovsky, Su, Sterling, Lok, Group (bb0045) 2012; 32 Zhu, Wang, Chen, Ma, Zhang, Su, Tian, Gai (bb0180) 2012; 7 Libreros, Iragavarapu-Charyulu (bb0095) 2015; 98 Nishikawa, Millis (bb0110) 2003; 287 Rathcke, Holmkvist, Jørgensen, Borch-Johnsen, Hansen, Pedersen, Vestergaard (bb0135) 2009; 4 Eurich, Segawa, Toei-Shimizu, Mizoguchi (bb0035) 2009; 15 Siegel, Ma, Zou, Jemal (bb0160) 2014; 64 Recklies, White, Ling (bb0140) 2002; 365 Lee (10.1016/j.mgene.2020.100686_bb0085) 2009; 206 Antonelli (10.1016/j.mgene.2020.100686_bb0005) 2012; 32 Zhao (10.1016/j.mgene.2020.100686_bb0165) 2007; 80 Mohammadian (10.1016/j.mgene.2020.100686_bb0105) 2018; 5 Hector (10.1016/j.mgene.2020.100686_bb0050) 2011; 6 Lee (10.1016/j.mgene.2020.100686_bb0090) 2010; 43 Johansen (10.1016/j.mgene.2020.100686_bb0070) 2009; 27 Zhu (10.1016/j.mgene.2020.100686_bb0175) 2012; 19 Brasso (10.1016/j.mgene.2020.100686_bb0010) 2006; 66 Erfan (10.1016/j.mgene.2020.100686_bb0030) 2015; 400 Faibish (10.1016/j.mgene.2020.100686_bb0040) 2011; 10 Janevska (10.1016/j.mgene.2020.100686_bb0060) 2015; 3 Nishikawa (10.1016/j.mgene.2020.100686_bb0110) 2003; 287 Siegel (10.1016/j.mgene.2020.100686_bb0160) 2014; 64 Huang (10.1016/j.mgene.2020.100686_bb0055) 2017; 14 Rathcke (10.1016/j.mgene.2020.100686_bb0135) 2009; 4 El-Zayadi (10.1016/j.mgene.2020.100686_bb0025) 2005; 11 Rehli (10.1016/j.mgene.2020.100686_bb0145) 2003; 278 Kruit (10.1016/j.mgene.2020.100686_bb0075) 2007; 101 Qiu (10.1016/j.mgene.2020.100686_bb0130) 2018; 8 Olaussen (10.1016/j.mgene.2020.100686_bb0120) 2006; 355 Libreros (10.1016/j.mgene.2020.100686_bb0100) 2013; 57 Zhu (10.1016/j.mgene.2020.100686_bb0180) 2012; 7 Eurich (10.1016/j.mgene.2020.100686_bb0035) 2009; 15 Fontana (10.1016/j.mgene.2020.100686_bb0045) 2012; 32 Kumagai (10.1016/j.mgene.2020.100686_bb0080) 2016; 6 Libreros (10.1016/j.mgene.2020.100686_bb0095) 2015; 98 Shao (10.1016/j.mgene.2020.100686_bb0155) 2009; 28 Di Rosa (10.1016/j.mgene.2020.100686_bb0015) 2016; 83 Zheng (10.1016/j.mgene.2020.100686_bb0170) 2011; 54 Edge (10.1016/j.mgene.2020.100686_bb0020) 2010 Oken (10.1016/j.mgene.2020.100686_bb0115) 1982; 5 Pelloski (10.1016/j.mgene.2020.100686_bb0125) 2005; 11 Shaker (10.1016/j.mgene.2020.100686_bb0150) 2016 Johansen (10.1016/j.mgene.2020.100686_bb0065) 2006; 53 Recklies (10.1016/j.mgene.2020.100686_bb0140) 2002; 365 |
References_xml | – volume: 66 start-page: 503 year: 2006 end-page: 513 ident: bb0010 article-title: Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma publication-title: Prostate contributor: fullname: Iversen – volume: 3 start-page: 732 year: 2015 end-page: 736 ident: bb0060 article-title: Hepatocellular carcinoma: risk factors, diagnosis and treatment publication-title: Maced. J. Med. Sci. contributor: fullname: Janevski – volume: 10 start-page: 742 year: 2011 end-page: 751 ident: bb0040 article-title: A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers publication-title: Mol. Cancer Ther. contributor: fullname: Shao – volume: 32 start-page: 665 year: 2012 end-page: 674 ident: bb0045 article-title: YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C publication-title: Liver Int. contributor: fullname: Group – volume: 6 start-page: 35282 year: 2016 ident: bb0080 article-title: Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease publication-title: Sci. Rep. contributor: fullname: Kanto – volume: 278 start-page: 44058 year: 2003 end-page: 44067 ident: bb0145 article-title: Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation publication-title: J. Biol. Chem. contributor: fullname: Krause – volume: 57 start-page: 99 year: 2013 end-page: 105 ident: bb0100 article-title: CHI3L1 plays a role in cancer through enhanced production of pro-inflammatory/pro-tumorigenic and angiogenic factors publication-title: Immunol. Res. contributor: fullname: Iragavarapu-Charyulu – volume: 4 year: 2009 ident: bb0135 article-title: Variation in CHI3LI in relation to type 2 diabetes and related quantitative traits publication-title: PLoS One contributor: fullname: Vestergaard – volume: 365 start-page: 119 year: 2002 end-page: 126 ident: bb0140 article-title: The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways publication-title: Biochem. J. contributor: fullname: Ling – volume: 101 start-page: 1563 year: 2007 end-page: 1571 ident: bb0075 article-title: A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker publication-title: Respir. Med. contributor: fullname: van den Bosch – volume: 355 start-page: 983 year: 2006 end-page: 991 ident: bb0120 article-title: DNA repair by ERCC1 in non–small-cell lung cancer and cisplatin-based adjuvant chemotherapy publication-title: N. Engl. J. Med. contributor: fullname: Soria – volume: 14 start-page: 136 year: 2017 end-page: 142 ident: bb0055 article-title: Correlation of chitinase 3-like 1 single nucleotide polymorphisms with hepatocellular carcinoma in Taiwan publication-title: Int. J. Med. Sci. contributor: fullname: Liu – volume: 287 start-page: 79 year: 2003 end-page: 87 ident: bb0110 article-title: gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells publication-title: Exp. Cell Res. contributor: fullname: Millis – year: 2010 ident: bb0020 article-title: The american joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM publication-title: Ann. Surg. Oncol. contributor: fullname: Compton – volume: 11 start-page: 3326 year: 2005 end-page: 3334 ident: bb0125 article-title: YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma publication-title: Clin. Cancer Res. contributor: fullname: Aldape – volume: 8 start-page: 1 year: 2018 end-page: 12 ident: bb0130 article-title: CHI3L1 promotes tumor progression by activating TGF-β signaling pathway in hepatocellular carcinoma publication-title: Sci. Rep. contributor: fullname: Lin – volume: 54 start-page: 51 year: 2011 end-page: 55 ident: bb0170 article-title: Genetic polymorphisms in chitinase 3-like 1 (CHI3L1) are associated with circulating YKL-40 levels, but not with angiographic coronary artery disease in a Chinese population publication-title: Cytokine contributor: fullname: Shen – volume: 80 start-page: 12 year: 2007 end-page: 18 ident: bb0165 article-title: Functional variants in the promoter region of chitinase 3–like 1 (CHI3L1) and susceptibility to schizophrenia publication-title: Am. J. Hum. Genet. contributor: fullname: He – volume: 19 start-page: 817 year: 2012 end-page: 825 ident: bb0175 article-title: Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery publication-title: Ann. Surg. Oncol. contributor: fullname: Ma – volume: 27 start-page: 572 year: 2009 end-page: 578 ident: bb0070 article-title: Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population publication-title: J. Clin. Oncol. contributor: fullname: Nordestgaard – volume: 15 start-page: 5249 year: 2009 end-page: 5259 ident: bb0035 article-title: Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells publication-title: World J. Gastroenterol. contributor: fullname: Mizoguchi – volume: 28 start-page: 4456 year: 2009 end-page: 4468 ident: bb0155 article-title: YKL-40, a secreted glycoprotein, promotes tumor angiogenesis publication-title: Oncogene contributor: fullname: Yan – start-page: 3 year: 2016 end-page: 4 ident: bb0150 article-title: Epidemiology of HCC in Egypt publication-title: Gastroenterol. Hepatol. contributor: fullname: Shaker – volume: 32 start-page: 133 year: 2012 end-page: 138 ident: bb0005 article-title: Expression of pERK and pAKT in pediatric high grade astrocytomas: correlation with YKL40 and prognostic significance publication-title: Neuropathology contributor: fullname: Giangaspero – volume: 83 start-page: 228 year: 2016 end-page: 242 ident: bb0015 article-title: Chitinase 3 Like-1: an emerging molecule involved in diabetes and diabetic complications publication-title: Pathobiology contributor: fullname: Malaguarnera – volume: 43 start-page: 1195 year: 2010 end-page: 1200 ident: bb0090 article-title: A promoter polymorphism −2122C>T of CHI3L1 is associated with serum low density lipoprotein cholesterol level in Korean subjects publication-title: Clin. Biochem. contributor: fullname: Yoon – volume: 5 start-page: 649 year: 1982 end-page: 655 ident: bb0115 article-title: Toxicity and response criteria of the eastern cooperative oncology group, Robert Comis M.D., group chair publication-title: Am. J. Clin. Oncol. contributor: fullname: Carbone – volume: 206 start-page: 1149 year: 2009 end-page: 1166 ident: bb0085 article-title: Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosis publication-title: J. Exp. Med. contributor: fullname: Elias – volume: 64 start-page: 9 year: 2014 end-page: 29 ident: bb0160 article-title: Cancer statistics, 2014 publication-title: CA Cancer J. Clin. contributor: fullname: Jemal – volume: 6 year: 2011 ident: bb0050 article-title: The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease publication-title: PLoS One contributor: fullname: Hartl – volume: 5 start-page: e1082 year: 2018 ident: bb0105 article-title: Liver cancer in the world : epidemiology, incidence, mortality and risk factors publication-title: world cancer resaerch J. contributor: fullname: Salehiniya – volume: 98 start-page: 931 year: 2015 end-page: 936 ident: bb0095 article-title: YKL-40/CHI3L1 drives inflammation on the road of tumor progression publication-title: J. Leukoc. Biol. contributor: fullname: Iragavarapu-Charyulu – volume: 7 year: 2012 ident: bb0180 article-title: Serum YKL-40 independently predicts outcome after transcatheter arterial chemoembolization of hepatocellular carcinoma publication-title: PLoS One contributor: fullname: Gai – volume: 400 start-page: 207 year: 2015 end-page: 212 ident: bb0030 article-title: Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis? publication-title: Mol. Cell. Biochem. contributor: fullname: Kulac – volume: 11 start-page: 5193 year: 2005 end-page: 5198 ident: bb0025 article-title: Hepatocellular carcinoma in Egypt: a single center study over a decade publication-title: World J. Gastroenterol. contributor: fullname: Saeid – volume: 53 start-page: 172 year: 2006 end-page: 209 ident: bb0065 article-title: Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer publication-title: Dan. Med. Bull. contributor: fullname: Johansen – volume: 287 start-page: 79 year: 2003 ident: 10.1016/j.mgene.2020.100686_bb0110 article-title: gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells publication-title: Exp. Cell Res. doi: 10.1016/S0014-4827(03)00069-7 contributor: fullname: Nishikawa – volume: 10 start-page: 742 year: 2011 ident: 10.1016/j.mgene.2020.100686_bb0040 article-title: A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-10-0868 contributor: fullname: Faibish – volume: 400 start-page: 207 year: 2015 ident: 10.1016/j.mgene.2020.100686_bb0030 article-title: Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis? publication-title: Mol. Cell. Biochem. doi: 10.1007/s11010-014-2277-y contributor: fullname: Erfan – volume: 5 start-page: e1082 year: 2018 ident: 10.1016/j.mgene.2020.100686_bb0105 article-title: Liver cancer in the world : epidemiology, incidence, mortality and risk factors publication-title: world cancer resaerch J. contributor: fullname: Mohammadian – start-page: 3 year: 2016 ident: 10.1016/j.mgene.2020.100686_bb0150 article-title: Epidemiology of HCC in Egypt publication-title: Gastroenterol. Hepatol. contributor: fullname: Shaker – volume: 98 start-page: 931 year: 2015 ident: 10.1016/j.mgene.2020.100686_bb0095 article-title: YKL-40/CHI3L1 drives inflammation on the road of tumor progression publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.3VMR0415-142R contributor: fullname: Libreros – volume: 4 year: 2009 ident: 10.1016/j.mgene.2020.100686_bb0135 article-title: Variation in CHI3LI in relation to type 2 diabetes and related quantitative traits publication-title: PLoS One doi: 10.1371/journal.pone.0005469 contributor: fullname: Rathcke – volume: 206 start-page: 1149 year: 2009 ident: 10.1016/j.mgene.2020.100686_bb0085 article-title: Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosis publication-title: J. Exp. Med. doi: 10.1084/jem.20081271 contributor: fullname: Lee – volume: 80 start-page: 12 year: 2007 ident: 10.1016/j.mgene.2020.100686_bb0165 article-title: Functional variants in the promoter region of chitinase 3–like 1 (CHI3L1) and susceptibility to schizophrenia publication-title: Am. J. Hum. Genet. doi: 10.1086/510438 contributor: fullname: Zhao – volume: 7 year: 2012 ident: 10.1016/j.mgene.2020.100686_bb0180 article-title: Serum YKL-40 independently predicts outcome after transcatheter arterial chemoembolization of hepatocellular carcinoma publication-title: PLoS One contributor: fullname: Zhu – volume: 32 start-page: 133 year: 2012 ident: 10.1016/j.mgene.2020.100686_bb0005 article-title: Expression of pERK and pAKT in pediatric high grade astrocytomas: correlation with YKL40 and prognostic significance publication-title: Neuropathology doi: 10.1111/j.1440-1789.2011.01252.x contributor: fullname: Antonelli – volume: 101 start-page: 1563 year: 2007 ident: 10.1016/j.mgene.2020.100686_bb0075 article-title: A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker publication-title: Respir. Med. doi: 10.1016/j.rmed.2006.12.006 contributor: fullname: Kruit – volume: 278 start-page: 44058 year: 2003 ident: 10.1016/j.mgene.2020.100686_bb0145 article-title: Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation publication-title: J. Biol. Chem. doi: 10.1074/jbc.M306792200 contributor: fullname: Rehli – volume: 83 start-page: 228 year: 2016 ident: 10.1016/j.mgene.2020.100686_bb0015 article-title: Chitinase 3 Like-1: an emerging molecule involved in diabetes and diabetic complications publication-title: Pathobiology doi: 10.1159/000444855 contributor: fullname: Di Rosa – volume: 54 start-page: 51 year: 2011 ident: 10.1016/j.mgene.2020.100686_bb0170 article-title: Genetic polymorphisms in chitinase 3-like 1 (CHI3L1) are associated with circulating YKL-40 levels, but not with angiographic coronary artery disease in a Chinese population publication-title: Cytokine doi: 10.1016/j.cyto.2010.12.018 contributor: fullname: Zheng – volume: 8 start-page: 1 year: 2018 ident: 10.1016/j.mgene.2020.100686_bb0130 article-title: CHI3L1 promotes tumor progression by activating TGF-β signaling pathway in hepatocellular carcinoma publication-title: Sci. Rep. doi: 10.1038/s41598-018-33239-8 contributor: fullname: Qiu – volume: 15 start-page: 5249 year: 2009 ident: 10.1016/j.mgene.2020.100686_bb0035 article-title: Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells publication-title: World J. Gastroenterol. doi: 10.3748/wjg.15.5249 contributor: fullname: Eurich – volume: 6 year: 2011 ident: 10.1016/j.mgene.2020.100686_bb0050 article-title: The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease publication-title: PLoS One doi: 10.1371/journal.pone.0024399 contributor: fullname: Hector – year: 2010 ident: 10.1016/j.mgene.2020.100686_bb0020 article-title: The american joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM publication-title: Ann. Surg. Oncol. doi: 10.1245/s10434-010-0985-4 contributor: fullname: Edge – volume: 43 start-page: 1195 year: 2010 ident: 10.1016/j.mgene.2020.100686_bb0090 article-title: A promoter polymorphism −2122C>T of CHI3L1 is associated with serum low density lipoprotein cholesterol level in Korean subjects publication-title: Clin. Biochem. doi: 10.1016/j.clinbiochem.2010.07.017 contributor: fullname: Lee – volume: 365 start-page: 119 year: 2002 ident: 10.1016/j.mgene.2020.100686_bb0140 article-title: The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways publication-title: Biochem. J. doi: 10.1042/bj20020075 contributor: fullname: Recklies – volume: 57 start-page: 99 year: 2013 ident: 10.1016/j.mgene.2020.100686_bb0100 article-title: CHI3L1 plays a role in cancer through enhanced production of pro-inflammatory/pro-tumorigenic and angiogenic factors publication-title: Immunol. Res. doi: 10.1007/s12026-013-8459-y contributor: fullname: Libreros – volume: 6 start-page: 35282 year: 2016 ident: 10.1016/j.mgene.2020.100686_bb0080 article-title: Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease publication-title: Sci. Rep. doi: 10.1038/srep35282 contributor: fullname: Kumagai – volume: 27 start-page: 572 year: 2009 ident: 10.1016/j.mgene.2020.100686_bb0070 article-title: Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2008.18.8367 contributor: fullname: Johansen – volume: 355 start-page: 983 year: 2006 ident: 10.1016/j.mgene.2020.100686_bb0120 article-title: DNA repair by ERCC1 in non–small-cell lung cancer and cisplatin-based adjuvant chemotherapy publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa060570 contributor: fullname: Olaussen – volume: 19 start-page: 817 year: 2012 ident: 10.1016/j.mgene.2020.100686_bb0175 article-title: Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery publication-title: Ann. Surg. Oncol. doi: 10.1245/s10434-011-2026-3 contributor: fullname: Zhu – volume: 11 start-page: 5193 year: 2005 ident: 10.1016/j.mgene.2020.100686_bb0025 article-title: Hepatocellular carcinoma in Egypt: a single center study over a decade publication-title: World J. Gastroenterol. contributor: fullname: El-Zayadi – volume: 14 start-page: 136 year: 2017 ident: 10.1016/j.mgene.2020.100686_bb0055 article-title: Correlation of chitinase 3-like 1 single nucleotide polymorphisms with hepatocellular carcinoma in Taiwan publication-title: Int. J. Med. Sci. doi: 10.7150/ijms.17754 contributor: fullname: Huang – volume: 32 start-page: 665 year: 2012 ident: 10.1016/j.mgene.2020.100686_bb0045 article-title: YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C publication-title: Liver Int. doi: 10.1111/j.1478-3231.2011.02686.x contributor: fullname: Fontana – volume: 28 start-page: 4456 year: 2009 ident: 10.1016/j.mgene.2020.100686_bb0155 article-title: YKL-40, a secreted glycoprotein, promotes tumor angiogenesis publication-title: Oncogene doi: 10.1038/onc.2009.292 contributor: fullname: Shao – volume: 66 start-page: 503 year: 2006 ident: 10.1016/j.mgene.2020.100686_bb0010 article-title: Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma publication-title: Prostate doi: 10.1002/pros.20311 contributor: fullname: Brasso – volume: 5 start-page: 649 year: 1982 ident: 10.1016/j.mgene.2020.100686_bb0115 article-title: Toxicity and response criteria of the eastern cooperative oncology group, Robert Comis M.D., group chair publication-title: Am. J. Clin. Oncol. doi: 10.1097/00000421-198212000-00014 contributor: fullname: Oken – volume: 3 start-page: 732 year: 2015 ident: 10.1016/j.mgene.2020.100686_bb0060 article-title: Hepatocellular carcinoma: risk factors, diagnosis and treatment publication-title: Maced. J. Med. Sci. doi: 10.3889/oamjms.2015.111 contributor: fullname: Janevska – volume: 53 start-page: 172 year: 2006 ident: 10.1016/j.mgene.2020.100686_bb0065 article-title: Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer publication-title: Dan. Med. Bull. contributor: fullname: Johansen – volume: 64 start-page: 9 year: 2014 ident: 10.1016/j.mgene.2020.100686_bb0160 article-title: Cancer statistics, 2014 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21208 contributor: fullname: Siegel – volume: 11 start-page: 3326 year: 2005 ident: 10.1016/j.mgene.2020.100686_bb0125 article-title: YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-04-1765 contributor: fullname: Pelloski |
SSID | ssj0001219516 |
Score | 1.8272405 |
Snippet | The chitinase 3-like 1 (CHI3L1) gene encodes the YKL-40 protein. Serum YKL-40 levels are controlled by polymorphisms in the CHI3L1 gene. We aimed to examine... |
SourceID | crossref elsevier |
SourceType | Aggregation Database Publisher |
StartPage | 100686 |
SubjectTerms | Chitinase 3-like 1 HCC Polymorphism YKL-40 |
Title | Chitinase 3-like 1 gene (T/C) polymorphism and serum YKL-40 levels in patients with hepatocellular carcinoma |
URI | https://dx.doi.org/10.1016/j.mgene.2020.100686 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEF5KRfAiPvFZ9uBBwdAkm2zTYy2WaqUHbbGewmYfNNqmxaYH_70zmwQqiAdPIY8ly7ebmdnNN98QcsUkBB2s5Tq-p1wnYEo6IhKYwMwiGTIphLYs3yHvj4PHSTipkW6VC4O0ytL2FzbdWuvySrNEs7lM0-aLjyLbgf2VhqpRqAnKQs8m8U3uNvZZPAgibI05eB55AG4lPmRpXnMYJ5TL9C1hgGNO9W8OasPp9PbIbhkt0k7RoX1S09kB2S7qR34dkll3muZpBo6IMmeWfmjqUXwRvR41uzd0uZjByh6ATFdzKjJFYbqt5_Rt8ATrOTpDutCKphkttVVXFDdl6RQcVL7ADX1kqFKJxYayxVwckXHvftTtO2X5BEeCX8qdBHy1awKpcMkSKh4FbSXaRrCWNoYnBm4aJkzbGFcJ7osAPkfdZiwUvtFuErJjUs8WmT4h1HANcaNRvmZhAM1FEjHDhYy4J4Qr1Sm5rTCLl4VKRlzRx95jC3GMEMcFxKeEV7jGPwY7Bjv-V8Oz_zY8Jzt4VnC8Lkg9_1zrS4gm8qRBtjoPg_4Qj4Pn10HDTp9v6hTKZQ |
link.rule.ids | 315,783,787,3513,24128,27936,27937,45691,45886 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEF5qRfQiPrE-9-BBwdA0m2yTowaltbUXW6insNkHjbZpsenBf-9MHlBBPHjNMiR8OzuPzTczhFwzCUEHa9uW01K25TIlLeELLGBmvvSYFELnLN8B74zc57E3rpGwqoVBWmVp-wubnlvr8kmzRLO5SJLmq4NNtt38Vxp2jXI3yCaWXaKad8cPaxctLYgi8iFzIIBEALvqPpTzvGawUdgv08kZAxyLqn_zUGte52mP7JbhIr0vvmif1HR6QLaKAZJfh2QaTpIsScETUWZNkw9NWxRfRG-GzfCWLuZTSO0ByWQ5oyJVFPRtNaNvvT4kdHSKfKElTVJaNlddUryVpRPwUNkcb_SRokolThtK5zNxREZPj8OwY5XzEywJjimzYnDWtnGlwpzFU9x3AyUCI1hbG8NjA4uGCRMYYyvBHeHCedQBY55wjLZjjx2TejpP9QmhhmsIHI1yNPNcEBexzwwX0uctIWypGuSuwixaFG0yooo_9h7lEEcIcVRA3CC8wjX6sdsRGPK_BE__K3hFtjvDl37U7w56Z2QHVwrC1zmpZ58rfQGhRRZf5qrzDZEdymI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chitinase+3-like+1+gene+%28T%2FC%29+polymorphism+and+serum+YKL-40+levels+in+patients+with+hepatocellular+carcinoma&rft.jtitle=Meta+Gene&rft.au=Saleh%2C+Amany+A.&rft.au=Alhanafy%2C+Alshimaa+M.&rft.au=Elbahr%2C+Osama&rft.au=El-Hefnawy%2C+Sally+M.&rft.date=2020-06-01&rft.pub=Elsevier+B.V&rft.issn=2214-5400&rft.eissn=2214-5400&rft.volume=24&rft_id=info:doi/10.1016%2Fj.mgene.2020.100686&rft.externalDocID=S2214540020300414 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2214-5400&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2214-5400&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2214-5400&client=summon |